In this episode, Jenny and Reut interview Ayla Annac, co-founder and CEO of Innovo Sciences, about AI's impact on healthcare and specifically on drug discovery for heart issues.

Ayla shares her personal journey and mission to find safe and effective drugs for heart failure, inspired by the loss of her father to the disease. She discusses the work of Innovo Sciences in developing cardiac precision discovery technologies that integrate patient-derived micro heart models and AI-driven diagnostics.

Takeaways

• AI can play a crucial role in drug discovery for heart issues by integrating patient-derived micro heart models and AI-driven diagnostics.
• Diversity in clinical trials is essential to ensure the effectiveness and safety of drugs for different populations.
• AI has the potential to empower individuals in managing their health by providing personalized data and insights.
• Ethics and transparency are critical in AI development to ensure responsible and beneficial use of the technology.

• Empowering Individuals in Healthcare with AI
• AI's Impact on Drug Discovery for Heart Issues

Chapters

00:00 Introduction to Ayla Annac and Innovo Sciences

04:01 Ayla's Personal Motivation and Mission

07:51 Patient-Derived Models and Precision Medicine

09:23 Matching Drugs to Subpopulations for Effective Treatment

13:00 The Importance of Diversity in Clinical Trials

14:50 Empowering Vulnerable Populations with AI

16:38 Ethical Use of AI in Healthcare

18:24 Keeping Humans in the Loop with AI

18:54 Protecting Small Creators and Ensuring Fair Innovation

20:44 Ethics and Integrity in AI

25:49 Connecting and Uniting with AI31:25Influential Women in the AI Space

34:44 Collaboration in Precision Cardiac Medicine Development

36:24 How the Women in AI Community Can Help